Taiwan FDA registration 5ce85a4461481a7423e36280ea0faedd
Revmed TriCeLL PRP KIT
TW: “芮渼” “三田” 血球細胞分離組
Taiwan·Risk Class 2·MD·REV-MED, Inc.·Registered Jun 22, 2016 – Jun 22, 2021ExpiredRegistration details
- Analysis ID
- 5ce85a4461481a7423e36280ea0faedd
- License Form
- Ministry of Health Medical Device Import No. 028448
- Customs Code
- DHA05602844800
Company information
- Manufacturer
- REV-MED, Inc.
- Manufacturer Country
- Korea, Republic of
- Authorized Representative
- AUGUSMED BIOTECH INC.
Product details
- Intended Use
- When this product is used, blood is removed from the patient, and an autologous platelet concentrate (PRP) is prepared by a secondary centrifugation procedure. When clinically indicated, autologous platelet concentrate can be mixed with bone implants (Bone graft) or used alone at orthopedic surgical sites.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B9245 Automatic Hematology Cell Separator
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jun 22, 2016
- Expiry Date
- Jun 22, 2021
About this record
Access comprehensive regulatory information for Revmed TriCeLL PRP KIT in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5ce85a4461481a7423e36280ea0faedd and manufactured by REV-MED, Inc.. The authorized representative in Taiwan is AUGUSMED BIOTECH INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices